MARKETS

BSE Prices delayed by 5 minutes... Prices as on Aug 16, 2019   ABB India 1359.75 [ 0.73% ]ACC 1590.5 [ -0.36% ]Ambuja Cements Ltd. 213.95 [ 0.02% ]Asian Paints Ltd. 1597 [ 1.77% ]Axis Bank Ltd. 675.55 [ 1.86% ]Bajaj Auto Ltd. 2750.15 [ 1.29% ]Bank of Baroda 102.4 [ 1.34% ]Bharti Airtel 361.3 [ 0.01% ]Bharat Heavy Ele 51.35 [ 0.59% ]Bharat Petroleum 351.35 [ -0.86% ]Britannia Ind. 2499.75 [ 0.76% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 476.25 [ -0.47% ]Coal India 201.85 [ 0.70% ]Colgate Palm. 1197.75 [ -0.19% ]Dabur India 428.15 [ -0.76% ]DLF Ltd. 177.7 [ 1.66% ]Dr. Reddy's Labs 2492.8 [ -0.73% ]GAIL (India) Ltd. 129.65 [ 2.33% ]Grasim Inds. 751.9 [ 2.35% ]HCL Technologies 1061.65 [ -1.37% ]HDFC 2098.75 [ -0.91% ]HDFC Bank 2226.65 [ -0.15% ]Hero MotoCorp 2667.85 [ 1.25% ]Hindustan Unilever L 1826.2 [ -0.61% ]Hindalco Indus. 179.75 [ -0.53% ]ICICI Bank 419.15 [ 0.43% ]IDFC L 34.3 [ 5.05% ]Indian Hotels Co 132.2 [ -1.64% ]IndusInd Bank 1438.25 [ 2.70% ]Infosys 774.55 [ -0.05% ]ITC Ltd. 252.9 [ 1.63% ]Jindal St & Pwr 103.7 [ -0.10% ]Kotak Mahindra Bank 1499.5 [ 0.51% ]L&T 1334.85 [ 0.06% ]Lupin Ltd. 729.4 [ -0.67% ]Mahi. & Mahi 527.6 [ 0.80% ]Maruti Suzuki India 5975.15 [ 2.74% ]MTNL 6.35 [ 3.42% ]Nestle India 12011.1 [ -0.16% ]NIIT Ltd. 93.35 [ -2.66% ]NMDC Ltd. 102.85 [ -1.72% ]NTPC 117.85 [ 0.21% ]ONGC 128.15 [ 1.10% ]Punj. NationlBak 68.1 [ 3.89% ]Power Grid Corpo 211.25 [ 2.85% ]Reliance Inds. 1277.4 [ -0.85% ]SBI 290.95 [ 0.38% ]Vedanta 144.3 [ -1.54% ]Shipping Corpn. 27 [ 1.50% ]Sun Pharma. 414.75 [ -0.55% ]Tata Chemicals 555.8 [ -1.23% ]Tata Global Beverage 266.85 [ -0.02% ]Tata Motors Ltd. 121.2 [ 0.29% ]Tata Steel 362.85 [ -0.44% ]Tata Power Co. 56.1 [ 1.08% ]Tata Consultancy 2163.5 [ -1.87% ]Tech Mahindra Ltd. 659.15 [ 0.03% ]UltraTech Cement 4212.05 [ -0.26% ]United Spirits 589.55 [ -0.08% ]Wipro Ltd 249.3 [ -0.74% ]Zee Entertainment En 346.5 [ 1.46% ]

News Details

You can view in detail.
Glenmark Pharmaceuticals gets ANDA nod for Sevelamer Hydrochloride tablets 11/02/2019 11:59

Drug maker Glenmark Pharmaceuticals Inc., USA (Glenmark) on Monday said that, “it has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg, a generic version of Renagel®1 Tablets, 400 mg and 800 mg, of Genzyme Corporation,” in a filing to Bombay Stock Exchange.

According to IQVIATM sales data for the 12 month period ending December 2018, the Renagel® Tablets, 400 mg and 800 mg market2 achieved annual sales of approximately $102.1 million.

“Glenmark’s current portfolio consists of 149 products authorized for distribution in the U.S. marketplace and 53 ANDA’s pending approval with the U.S. FDA,” the company said.

In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

The shares of the company were trading at 605.00 apiece, low at 9.45 points or 1.54 per cent at 11:55 hours on the BSE.

LOAD MORE